Ivermectin

[Open_Window]

Ivermectin being studied for COVID 19 || COVID Medication Update Today

Ivermectin and COVID 19

Ivermectin Works For COVID-19 - LATEST STUDIES

[Schrodinger]

Coronavirus 2020

So no aparrent benefit.

[Open_Window]

60 minutes of video, reply 1m post OP - which speed setting did you use on youtube… warp speed?

[Schrodinger]

I was looking this up recently.

If you had searched your own site you would have found this.

[Open_Window]

Early Outpatient Treatment: An Essential Part of a COVID-19 Solution, Part II

I was looking this up recently.

If you had searched your own site you would have found this.

Yes, it’s getting a lot of attention again recently.

[Schrodinger]

This is interesting though.

And gives dosage recommendations.

https://osf.io/wx3zn/?fbclid=IwAR1D8zI_SzOtaFAOG840QYFfdtvjcNxtd38-ej-hG_uj_RBIbkKYwCHnUbQ

The FLCCC recommendation is based on the following set of conclusions derived from the existing
data, which will be comprehensively reviewed below:

1. Since 2012, multiple in-vitro studies have demonstrated that Ivermectin inhibits the replication of many viruses, including influenza, Zika, Dengue and others (Mastrangelo et al., 2012;Wagstaff et al., 2012;Tay et al., 2013;Götz et al., 2016;Varghese et al., 2016;Atkinson et al., 2018;Lv et al., 2018;King et al., 2020;Yang et al., 2020)

2. Ivermectin inhibits SARS CoV-2 replication and binding to host tissue via several observed and proposed mechanisms (Caly et al., 2020b)

3. Ivermectin has potent anti-inflammatory properties with in-vitro data demonstrating profound inhibition of both cytokine production and transcription of nuclear factor-κB (NF-κB), the most potent mediator of inflammation (Zhang et al., 2008;Ci et al., 2009;Zhang et al., 2009)

4. Ivermectin significantly diminishes viral load and protects against organ damage in multiple animal models when infected with SARS-CoV-2 or similar coronaviruses (Arevalo et al., 84 2020;de Melo et al., 2020)

[Schrodinger]

A [preprint] (https://en.wikipedia.org/wiki/Preprint) published in April 2020 claimed benefits of ivermectin in the treatment of COVID-19, but it was a retrospective study based on questionable hospital data from Surgisphere and was withdrawn at the end of May. The preprint led to several government agencies in Latin America recommending ivermectin as a COVID-19 treatment; these recommendations were later denounced by the regional WHO office.[83] On October 12, 2020 Peru withdrew its authorization to use ivermectin and hydroxychloroquine as COVID-19 treatments.[84]

There is only very weak evidence of ivermectin’s benefit when used as an add-on therapy for people with non-severe COVID-19.[85]

The National Institutes of Health recommend against the use ivermectin for COVID-19.[86]

Ivermectin | COVID-19

[Open_Window]

Ivermectin is Now a Therapeutic Option for Doctors & Prescribers!

Jan 14, 2021 – One week after Dr. Paul Marik and Dr. Pierre Kory – founding members of the Front Line Covid-19 Critical Care Alliance (FLCCC) – along with Dr. Andrew Hill, researcher and consultant to the World Health Organization (WHO), presented their data before the NIH Treatment Guidelines Panel, the NIH has upgraded their recommen­da­tion and now considers Ivermectin an option for use in COVID-19.

Their recommendation has now been upgraded to the same level as those for widely used monoclonal antibodies & convalescent plasma, which is a “neither for nor against” recommen­da­tion. The significance of this change is that the NIH has decided to no longer recommend against the use of ivermectin in the treatment of COVID-19 by the nation’s health care providers. A consequence of this change is that ivermectin has now been made a clear therapeutic option for patients.

https://covid19criticalcare.com

[Open_Window]

This new designation upgraded the status of ivermectin from “against” to “neither for nor against”, which is the same recommendation given to monoclonal antibodies and convalescent plasma, both widely used across the nation.

By no longer recommending against ivermectin use, doctors should feel more open in prescribing ivermectin as another therapeutic option for the treatment of COVID-19. This may clear its path towards FDA emergency use approval.

Full text here: https://www.newswise.com/coronavirus/nih-revises-treatment-guidelines-for-ivermectin-for-the-treatment-of-covid-19